Organisation
Clinical and Diagnostic Immunology
Lab
This laboratory studies the regulation of the immune response to Streptococcus pneumoniae, immunodeficiencies (with particular interest on innate immunity), and autoimmunity (with particular interest on serological markers).
Current researchers
1 - 8 of 8 results
- Xavier Bossuyt (Responsible)
- Xavier Bossuyt (Member)
- Jonas De Leeuw (Member)
- Lisa Dewitte (Member)
- Glynis Frans (Member)
- Louis Nevejan (Member)
- Lieve Van Hoovels (Member)
- Jean-Baptiste Vulsteke (Member)
Projects
1 - 10 of 36
- Ultra-sensitive minimal residual disease assessment by blood-based clonotypic mass spectrometry approach in plasma cell dyscrasias (MASSIAS)From1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization of allergen-specific T and B cells associated with tolerance induction in food allergic childrenFrom1 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- B-specific: B-cell related gene and protein markers with prognostic and therapeutic value for CVDFrom1 Oct 2023 → TodayFunding: Horizon Europe - European Innovation Council (EIC)
- Closing the seronegative gap in rheumatoid arthritis diagnosis using B-cell receptor sequencing combined with mass spectrometric analysis of complementarity determining regions.From1 Oct 2023 → TodayFunding: Other federal public and semi-governmental institutions
- Ultra-sensitive minimal residual disease assessment by blood-based clonotypic mass spectrometry approach in plasma cell dyscrasias (MASSIAS)From1 Oct 2023 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Mass spectrometry based immunoprofiling in rheumatoid arthritis patientsFrom1 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeted mass spectrometry-based quantification of autoantibodies in systemic rheumatic diseasesFrom1 Oct 2021 → 30 Sep 2023Funding: FWO Applied Biomedical Research (TBM)
- Why dose lung damage sometimes continue to worsen after the body seems to have cleared the SARS-CoV-2 virus?From1 Oct 2021 → 31 Mar 2023Funding: Foreign private sponsor - undefined
- Tumor necrosis factor Receptor-Associated Factors in signal transduction and susceptibility to infection.From9 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Tumor necrosis factor Receptor-Associated Factors in signal transduction and susceptibility to infection.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
Publications
1 - 10 of 432
- Interpretatie van laboratoriumresultaten(2016)
Authors: Xavier Bossuyt, Peter Peter E. Declercq
Pages: 37 - 45 - Functionele regulatie van MMP-9 door posttranslationele modificaties(2020)
Authors: Lise Boon, Ghislain Opdenakker
- The diagnosis of celiac disease in the laboratory: Current recommendations(2014)
Authors: Xavier Bossuyt
Pages: 15 - 20 - Clinical association of mixed connective tissue disease and granulomatosis with polyangiitis: a case report and systematic screening of anti-U1RNP and anti-PR3 auto-antibody double positivity in ten European hospitals(2016)
Authors: Amandine Tubery, Françoise Fortenfant, Bernard Combe, Isabelle Abreu, Xavier Bossuyt, Pascale Chretien, Sophie Desplat-Jégo, Nicole Fabien, Sophie Hue, Catherine Johanet, et al.
Pages: 1243 - 1246 - Anti-Hmgcr Antibodies As Specific Marker for Immune Mediated Necrotizing Myopathies(2015)
Authors: Lucile Musset, Chelsea Bentow, Marvin J Fritzler, Jiri Vencovsky, Olivier Benveniste, Ignacio Garcia de la Torre, Franco Franceschini, Katalin Danko, Qinglin Peng, Sophie Hue, et al.
- Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders(2009)
Authors: Pieter Vermeersch, Martine Vercammen, Annelies Holvoet, Isabelle Vande Broeck, Michel Delforge, Xavier Bossuyt
Pages: 54 - 58 - Serological markers in inflammatory bowel disease(2008)
Authors: Séverine Vermeire, Paul Rutgeerts, Xavier Bossuyt
Pages: 358 - 367 - Analytical performance evaluation of four cartridge-type blood gas analyzers(2012)
Authors: Lieve Van Hoovels
Pages: 1083 - 1091 - Evaluation of Autoantibodies in Patients with Primary and Secondary Sjogren's Syndrome(2017)
Authors: Ellen De Langhe, Xavier Bossuyt
Pages: 10 - 15 - A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)(2011)
Authors: Xavier Bossuyt
Pages: 747 - 54